Tristel plc (LON:TSTL - Get Free Report)'s stock price passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of GBX 450.21 ($5.89) and traded as low as GBX 385 ($5.04). Tristel shares last traded at GBX 388 ($5.08), with a volume of 19,698 shares traded.
The stock's fifty day simple moving average is GBX 446.69 and its two-hundred day simple moving average is GBX 450.21. The stock has a market capitalization of £183.93 million, a P/E ratio of 2,984.62 and a beta of 0.23. The company has a debt-to-equity ratio of 19.12, a quick ratio of 3.83 and a current ratio of 4.92.
In related news, insider Elizabeth Dixon sold 50,000 shares of the company's stock in a transaction that occurred on Thursday, September 19th. The stock was sold at an average price of GBX 397 ($5.20), for a total value of £198,500 ($259,782.75). 4.89% of the stock is owned by corporate insiders.
Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom and internationally. The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other. It offers medical instrument disinfection products, including airway management, cardiology, ear, nose and throat, endoscopy, gastrointestinal physiology, laboratory, ophthalmology, phlebotomy, reproductive health/IVF, surface, ultrasound, urology, women's health, and other products under the Tristel brand.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Tristel, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tristel wasn't on the list.
While Tristel currently has a "hold" rating among analysts, top-rated analysts believe these five stocks are better buys.